FACTORS ASOCIATED WITH OSTEOPOROSIS AND BMD LOSS IN A COHORT OF WOMEN WITH BREAST CANCER TREATED WITH AROMATASE INHIBITORS

被引：0
|
作者：
Loarce-Martos, J. [1 ]
Sifuentes-Giraldo, W. A. [1 ]
Maldonado-Romero, L. V. [1 ]
Ahijon-Lana, M. [1 ]
Velazquez-Arce, C. [1 ]
Martinez-Janez, N. [1 ]
Vazquez-Diaz, M. [1 ]
机构：
[1] Hosp Univ Ramon Y Cajal, Madrid, Spain
来源：
OSTEOPOROSIS INTERNATIONAL | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P895
引用
收藏
页码：S445 / S445
页数：1
相关论文
共 50 条
  • [1] BONE LOSS IN WOMEN WITH BREAST CANCER TREATED WITH AROMATASE INHIBITORS
    Zodelava, M.
    Tsikhiseli, G.
    Nijaradze, S.
    Tskhovrebashvili, N.
    Tatishvili, N.
    Tskhovrebashvili, M.
    Mamaladze, T.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2017, 28 : S465 - S465
  • [2] A retrospective study on screening and management of osteoporosis in breast cancer women treated with aromatase inhibitors in Libya
    Abushwereb, Hanan Saaddedin
    Elhabash, M.
    Elhamshari, S.
    Eshaefi, H.
    [J]. CLINICAL CASES IN MINERAL AND BONE METABOLISM, 2016, 13 (03) : 186 - 189
  • [3] PREDICTIVE FACTORS OF LONGITUDINAL BONE LOSS IN PATIENTS TREATED WITH AROMATASE INHIBITORS FOR BREAST CANCER
    Fowler, J.
    Mitchell, K.
    Bukhari, M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 764 - 765
  • [4] Effects of denosumab on bone mineral density in Japanese women with osteoporosis treated with aromatase inhibitors for breast cancer
    Katsuhiko Nakatsukasa
    Hiroshi Koyama
    Yoshimi Ouchi
    Kouichi Sakaguchi
    Yoshifumi Fujita
    Takayuki Matsuda
    Makoto Kato
    Eiichi Konishi
    Tetsuya Taguchi
    [J]. Journal of Bone and Mineral Metabolism, 2019, 37 : 301 - 306
  • [5] Effects of denosumab on bone mineral density in Japanese women with osteoporosis treated with aromatase inhibitors for breast cancer
    Nakatsukasa, Katsuhiko
    Koyama, Hiroshi
    Ouchi, Yoshimi
    Sakaguchi, Kouichi
    Fujita, Yoshifumi
    Matsuda, Takayuki
    Kato, Makoto
    Konishi, Eiichi
    Taguchi, Tetsuya
    [J]. JOURNAL OF BONE AND MINERAL METABOLISM, 2019, 37 (02) : 301 - 306
  • [6] Fragility Fracture Risk Reduction in Women with Breast Cancer on Aromatase Inhibitors Treated with Anti-Osteoporosis Therapy
    Cheng, Yu-Chien
    Bullock, Cydney
    Gandhi, Shriya
    Sterenstein, Andrea
    Randall, Megan
    Ahmad, Sara
    Thakkar, Samarthkumar
    Morkos, Michael
    Meier, Garnet
    Baim, Sanford
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2018, 33 : 317 - 317
  • [7] The use of aromatase inhibitors for breast cancer treatment and osteoporosis
    Cassol, Lina B.
    Garicochea, Bernardo
    [J]. SCIENTIA MEDICA, 2005, 15 (04) : 279 - 286
  • [8] Management of bone loss in postmenopausal breast cancer patients treated with aromatase inhibitors
    Cepa, M.
    Vaz, C.
    [J]. ACTA REUMATOLOGICA PORTUGUESA, 2015, 40 (04): : 323 - 330
  • [9] Osteoporosis treatment and 10 years' oestrogen receptor plus breast cancer outcome in postmenopausal women treated with aromatase inhibitors
    Bouvard, B.
    Chatelais, J.
    Soulie, P.
    Hoppe, E.
    Saulnier, P.
    Capitain, O.
    Mege, M.
    Mesgouez-Nebout, N.
    Jadaud, E.
    Abadie-Lacourtoisie, S.
    Campone, M.
    Legrand, E.
    [J]. EUROPEAN JOURNAL OF CANCER, 2018, 101 : 87 - 94
  • [10] Screening for Osteoporosis in Postmenopausal Women With Breast Cancer Receiving Aromatase Inhibitors: Less Is More?
    Dhesy-Thind, Sukhbinder K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (13) : 1408 - 1410
12345